As a result, JAK3 plays an essential role in development, differentiation, proliferation and survival of T-cells [20] and, as we have previously reported, JAK3 mutations are associated with metastatic spread and poor survival of RCC patients [21]. This evidence concerns the gene JAK3 and renal cell carcinoma.